The role of innate immunity in atherogenesis11 Guest editor for this article was Linda Curtiss, the Scripps Research Institute. Published, JLR Papers in Press, December 22, 2008.

Lipid peroxidation is a common event in health and is greatly accelerated in pro-inflammatory settings such as hypercholesterolemia. Consequently, oxidation-specific epitopes are generated, which are pro-inflammatory and immunogenic, leading to both adaptive and innate responses. Because innate immune mechanisms use conserved germline pattern recognition receptors (PRRs) that are preformed and present at birth, it is not obvious why they should bind to such epitopes. In this review, we put forward the hypothesis that because oxidation-specific epitopes are ubiquitous in both health and disease, and because they in essence represent “danger signals,” they constitute a class of pathogen-associated molecular patterns leading to the natural selection of multiple innate PRRs that target such epitopes. We suggest that apoptotic cells, and the blebs and microparticles released from such cells, which are rich in oxidation-specific epitopes and thus pro-inflammatory, constitute an endogenous set of selecting antigens. In turn, natural antibodies, scavenger receptors, and soluble innate proteins, such as pentraxins, all represent PRRs that target such epitopes. We discuss the evidence for this hypothesis and the consequences of such responses in health and disease, such as atherosclerosis.

[1]  D. Webb,et al.  Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4 , 2008, Journal of Biological Chemistry.

[2]  V. Fuster,et al.  Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes , 2008, Circulation.

[3]  S. Hazen Oxidized Phospholipids as Endogenous Pattern Recognition Ligands in Innate Immunity* , 2008, Journal of Biological Chemistry.

[4]  J. Witztum,et al.  Oxidation‐specific epitopes are important targets of innate immunity , 2008, Journal of internal medicine.

[5]  Arthur S Slutsky,et al.  Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury , 2008, Cell.

[6]  J. Witztum,et al.  Natural antibodies in murine atherosclerosis. , 2008, Current drug targets.

[7]  S. Gordon,et al.  Macrophage scavenger receptors and host-derived ligands. , 2007, Methods.

[8]  S. Kaveri,et al.  Phosphorylcholine-targeting immunization reduces atherosclerosis. , 2007, Journal of the American College of Cardiology.

[9]  J. Witztum,et al.  Promise of immune modulation to inhibit atherogenesis. , 2007, Journal of the American College of Cardiology.

[10]  L. Herzenberg,et al.  Division and differentiation of natural antibody-producing cells in mouse spleen , 2007, Proceedings of the National Academy of Sciences.

[11]  E. Brilakis,et al.  Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events Published, JLR Papers in Press, November 8, 2006. , 2007, Journal of Lipid Research.

[12]  Stanley L. Hazen,et al.  Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells , 2006, The Journal of experimental medicine.

[13]  P. Shah,et al.  Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. , 2006, Atherosclerosis.

[14]  S. Gordon,et al.  The interaction of macrophage receptors with bacterial ligands , 2006, Expert Reviews in Molecular Medicine.

[15]  A. Brewer,et al.  GATA factors in vertebrate heart development and disease , 2006, Expert Reviews in Molecular Medicine.

[16]  J. Witztum,et al.  A Natural Antibody to Oxidized Cardiolipin Binds to Oxidized Low-Density Lipoprotein, Apoptotic Cells, and Atherosclerotic Lesions , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[18]  J. Witztum,et al.  Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.R500005-JLR200 , 2005, Journal of Lipid Research.

[19]  D. S. Worrall,et al.  Toll-Like Receptor 4–Dependent and –Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[20]  G. Getz Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400013-JLR200 , 2005, Journal of Lipid Research.

[21]  K. Elkon,et al.  IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo , 2005, Autoimmunity.

[22]  P. Shah,et al.  Immunomodulation of atherosclerosis: implications for vaccine development. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Witztum,et al.  The role of natural antibodies in atherogenesis. , 2005, Journal of lipid research.

[24]  L. Herzenberg,et al.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.

[25]  Jianfei Jiang,et al.  Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. , 2004, Free radical biology & medicine.

[26]  J. Witztum,et al.  Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory , 2004, The Journal of experimental medicine.

[27]  B. Strauss,et al.  Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein , 2004, Circulation.

[28]  R. Hardy,et al.  Selection during development of VH11+ B cells: a model for natural autoantibody‐producing CD5+ B cells , 2004, Immunological reviews.

[29]  J. Berliner,et al.  Receptors Involved in the Oxidized 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated Synthesis of Interleukin-8 , 2003, Journal of Biological Chemistry.

[30]  J. Witztum,et al.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.

[31]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[32]  J. Witztum,et al.  Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.

[33]  J. Witztum,et al.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Sobue,et al.  Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease , 2002, Acta Neuropathologica.

[35]  E. Dennis,et al.  Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids , 2002, The Journal of Biological Chemistry.

[36]  B. Binder,et al.  Oxidized Membrane Vesicles and Blebs From Apoptotic Cells Contain Biologically Active Oxidized Phospholipids That Induce Monocyte‐Endothelial Interactions , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[37]  D. Steinberg,et al.  Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. , 2001, Journal of lipid research.

[38]  G. Silverman,et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.

[39]  A. Lustig,et al.  Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Y. Chao,et al.  Infectious Agents Are Not Necessary for Murine Atherogenesis , 2000, The Journal of experimental medicine.

[41]  E. Dennis,et al.  The Binding of Oxidized Low Density Lipoprotein to Mouse CD36 Is Mediated in Part by Oxidized Phospholipids That Are Associated with Both the Lipid and Protein Moieties of the Lipoprotein* , 2000, The Journal of Biological Chemistry.

[42]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[43]  E. Dennis,et al.  Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[45]  V. Monnier,et al.  Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. , 1997, The Journal of clinical investigation.

[46]  J. Witztum,et al.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.

[47]  J. Witztum,et al.  Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. , 1994, The Journal of clinical investigation.

[48]  M. Krieger Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. , 1992, Trends in biochemical sciences.

[49]  M. Freeman,et al.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Ylä-Herttuala,et al.  Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. , 1990, Arteriosclerosis.

[51]  J L Witztum,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[52]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.